vs
AGENUS INC（AGEN）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
AGENUS INC的季度营收约是RBB Bancorp的1.1倍（$34.2M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -31.0%，领先62.5%），AGENUS INC同比增速更快（27.5% vs 12.6%），过去两年AGENUS INC的营收复合增速更高（10.5% vs 7.0%）
Agenus Inc.是一家总部位于美国马萨诸塞州列克星敦的生物技术公司，核心业务聚焦免疫治疗领域，尤其专注于利用人体免疫系统控制或治愈癌症的肿瘤免疫治疗。公司目前正在研发检查点调节剂、个性化抗癌疫苗，以及可适配多种疫苗的免疫佐剂，其中检查点调节剂作为当前进展迅速的方向，早期产品已为患者带来突破性临床获益。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
AGEN vs RBB — 直观对比
营收规模更大
AGEN
是对方的1.1倍
$32.3M
营收增速更快
AGEN
高出14.9%
12.6%
净利率更高
RBB
高出62.5%
-31.0%
两年增速更快
AGEN
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $32.3M |
| 净利润 | $-10.6M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | 42.1% | 39.5% |
| 净利率 | -31.0% | 31.5% |
| 营收同比 | 27.5% | 12.6% |
| 净利润同比 | 77.3% | 132.1% |
| 每股收益（稀释后） | $0.09 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGENRBB
| Q4 25 | $34.2M | $32.3M | ||
| Q3 25 | $30.2M | $32.6M | ||
| Q2 25 | $25.7M | $35.8M | ||
| Q1 25 | $24.1M | $28.5M | ||
| Q4 24 | $26.8M | $28.7M | ||
| Q3 24 | $25.1M | $30.3M | ||
| Q2 24 | $23.5M | $27.5M | ||
| Q1 24 | $28.0M | $28.2M |
净利润AGENRBB
| Q4 25 | $-10.6M | $10.2M | ||
| Q3 25 | $63.9M | $10.1M | ||
| Q2 25 | $-30.0M | $9.3M | ||
| Q1 25 | $-26.4M | $2.3M | ||
| Q4 24 | $-46.8M | $4.4M | ||
| Q3 24 | $-67.2M | $7.0M | ||
| Q2 24 | $-54.8M | $7.2M | ||
| Q1 24 | $-63.5M | $8.0M |
毛利率AGENRBB
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
营业利润率AGENRBB
| Q4 25 | 42.1% | 39.5% | ||
| Q3 25 | -15.0% | 40.7% | ||
| Q2 25 | -65.0% | 36.1% | ||
| Q1 25 | -55.3% | 11.2% | ||
| Q4 24 | -96.5% | 17.6% | ||
| Q3 24 | -125.5% | 31.6% | ||
| Q2 24 | -128.4% | 35.6% | ||
| Q1 24 | -117.4% | 39.9% |
净利率AGENRBB
| Q4 25 | -31.0% | 31.5% | ||
| Q3 25 | 211.4% | 31.2% | ||
| Q2 25 | -116.8% | 26.1% | ||
| Q1 25 | -109.6% | 8.0% | ||
| Q4 24 | -174.4% | 15.3% | ||
| Q3 24 | -267.7% | 23.1% | ||
| Q2 24 | -233.1% | 26.4% | ||
| Q1 24 | -226.6% | 28.4% |
每股收益（稀释后）AGENRBB
| Q4 25 | $0.09 | $0.59 | ||
| Q3 25 | $1.94 | $0.59 | ||
| Q2 25 | $-1.00 | $0.52 | ||
| Q1 25 | $-1.03 | $0.13 | ||
| Q4 24 | $-1.95 | $0.26 | ||
| Q3 24 | $-3.08 | $0.39 | ||
| Q2 24 | $-2.52 | $0.39 | ||
| Q1 24 | $-3.04 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $212.3M |
| 总债务越低越好 | $44.7M | $119.9M |
| 股东权益账面价值 | $-271.1M | $523.4M |
| 总资产 | $226.8M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资AGENRBB
| Q4 25 | $3.0M | $212.3M | ||
| Q3 25 | $3.5M | $234.9M | ||
| Q2 25 | $9.5M | $191.9M | ||
| Q1 25 | $18.5M | $238.8M | ||
| Q4 24 | $40.4M | $257.7M | ||
| Q3 24 | $44.8M | $349.4M | ||
| Q2 24 | $93.7M | $252.8M | ||
| Q1 24 | $52.9M | — |
总债务AGENRBB
| Q4 25 | $44.7M | $119.9M | ||
| Q3 25 | $34.2M | $119.8M | ||
| Q2 25 | $33.9M | $119.7M | ||
| Q1 25 | $33.6M | $119.6M | ||
| Q4 24 | $33.2M | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益AGENRBB
| Q4 25 | $-271.1M | $523.4M | ||
| Q3 25 | $-274.1M | $514.3M | ||
| Q2 25 | $-354.6M | $517.7M | ||
| Q1 25 | $-341.8M | $510.3M | ||
| Q4 24 | $-326.4M | $507.9M | ||
| Q3 24 | $-292.3M | $509.7M | ||
| Q2 24 | $-241.3M | $511.3M | ||
| Q1 24 | $-201.4M | $514.0M |
总资产AGENRBB
| Q4 25 | $226.8M | $4.2B | ||
| Q3 25 | $233.9M | $4.2B | ||
| Q2 25 | $185.2M | $4.1B | ||
| Q1 25 | $200.2M | $4.0B | ||
| Q4 24 | $226.3M | $4.0B | ||
| Q3 24 | $238.5M | $4.0B | ||
| Q2 24 | $292.4M | $3.9B | ||
| Q1 24 | $256.6M | $3.9B |
负债/权益比AGENRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.6M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | — | $42.6M |
| 自由现金流率自由现金流/营收 | — | 131.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | — | $73.5M |
8季度趋势，按日历期对齐
经营现金流AGENRBB
| Q4 25 | $-16.6M | $43.4M | ||
| Q3 25 | $-14.7M | $2.1M | ||
| Q2 25 | $-20.2M | $21.7M | ||
| Q1 25 | $-25.6M | $7.8M | ||
| Q4 24 | $-28.7M | $58.5M | ||
| Q3 24 | $-53.3M | $24.5M | ||
| Q2 24 | $-38.2M | $11.7M | ||
| Q1 24 | $-38.2M | $4.8M |
自由现金流AGENRBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | $-20.2M | $21.6M | ||
| Q1 25 | $-25.6M | $7.6M | ||
| Q4 24 | $-28.7M | $57.7M | ||
| Q3 24 | $-53.3M | $24.2M | ||
| Q2 24 | $-38.6M | $11.5M | ||
| Q1 24 | $-38.2M | $4.7M |
自由现金流率AGENRBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | -78.7% | 60.2% | ||
| Q1 25 | -106.5% | 26.7% | ||
| Q4 24 | -107.0% | 201.0% | ||
| Q3 24 | -212.2% | 80.0% | ||
| Q2 24 | -164.4% | 42.0% | ||
| Q1 24 | -136.5% | 16.6% |
资本支出强度AGENRBB
| Q4 25 | 0.0% | 2.5% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.3% | 2.7% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 2.0% | 0.5% | ||
| Q1 24 | 0.1% | 0.5% |
现金转化率AGENRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | -0.23× | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
RBB
暂无分部数据
